- Location: Drapers' Hall, London
- Date: Wednesday 12th July 2023
- Price: £150.00 + VAT
(Non-Members: £150.00 + VAT)
After almost 40 years, Sharon Finch will be stepping down from the PLG Board of Directors, which seems a good opportunity to hold a retrospective to look at how the deal making landscape has changed over this time, with views from big pharma, mid-cap and biotech.
Shaun Grady, Vice-President Business Development Operations at AstraZeneca, Paul Pay, ex CBO at Norgine and Dr Andy Richards CBE will provide their thoughts and experiences across 40 years of deal-making.
|5.15pm||Welcome & Introduction
Vice-President Business Development Operations, AstraZeneca
|5.40pm||ANDY RICHARDS CBE|
Company Advisor and NED
|6.20pm||Networking drinks reception and canapes|